Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Honasa Consumer

Stocks in news: Indigo Paints, LG Electronics India, Tata Motors PV, Honasa Consumer, Ashok Leyland, Physicswallah

Indian equity markets saw a decline on Thursday, August 13, with the Nifty 50 closing lower. Persistent Middle East tensions and a stronger US dollar influenced investor sentiment negatively. Several companies like Indigo Paints and LG Electronics India reported their first-quarter earnings results. Other firms such as Ashok Leyland and…

The Economic Times

Honasa Consumer Q1 Results: Mamaearth parent posts record profit of Rs 90 crore; revenue up 27% YoY

Honasa Consumer, the parent of Mamaearth, reported a record Rs 90 crore consolidated PAT in Q1FY27, up 116.5% YoY. Revenue rose 27% to Rs 756 crore, while EBITDA surged 141% to Rs 110 crore. Strong growth across focus categories, brands and offline channels supported the company’s performance.

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Tuesday

Indian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 372 points and Nifty lost 110, while analysts advised a buy-on-dips strategy above the key 23,800 support level.

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata Motors

Indian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, and Infosys are in focus due to significant developments. Vedanta saw a major promoter stake sale, while Honasa Consumer plans an acquisition. Bajaj Auto reported a ransomware…

The Economic Times

Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence Pharma

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry into the health and wellness supplements market. This strategic move aims to leverage Fluence's patented technology and dermatologist network to expand Honasa's 'inside-out' beauty solutions. The acquisition is…

The Economic Times

Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuation

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's second acquisition in under a year, following its purchase of Reginald Men in December.

The Economic Times

Fable 5's cost challenge; Opendoor's India exit

Anthropic's Fable 5 could rewrite how IT works, but the price tag and performance quirks raise hard questions. This and more in today’s ETtech Top 5.

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Honasa shares jump 6% on Rs 5,500 crore revenue target by FY31. What is Goldman Sachs saying?

Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth rate of around 18% between FY26 and FY31. Growth is expected to be led by Mamaearth, with revenue projected to exceed ₹2,000 crore, while The Derma Co is…

The Economic Times

Nykaa vs Honasa: Which stock should you buy after Q4 earnings? Here’s what experts say

Nykaa and Mamaearth parent companies saw share surges Friday. Both beauty firms reported strong profit jumps. International brokerages issued bullish calls. Nykaa's parent, FSN E-Commerce Ventures, posted a 286% profit increase. Mamaearth's parent, Honasa Consumer, reported a 177% profit jump. Analysts suggest patience for fresh investments in these stocks.

The Economic Times

Ahead of Market: 10 things that will decide stock market action on Monday

Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.

The Economic Times

Can Honasa shares rally up to 57% after strong Q4 show? Jefferies, CLSA & two other brokerages weigh in

Honasa Consumer shares surged over 11% on Friday after a strong Q4 FY26 performance, with brokerages including Jefferies, CLSA, ICICI Securities and JM Financial turning more optimistic. Jefferies sees up to 57% upside, citing robust multi-channel growth, improving margins and stronger execution, while other brokerages also highlight rising traction across…

The Economic Times

Honasa Consumer shares zoom 11% on robust Q4. Jefferies, CLSA see more room to run

Honasa Consumer, Mamaearth's parent company, saw its shares surge after reporting a 177% year-on-year jump in net profit to Rs 69 crore for Q4 FY26. Revenue also climbed over 23% to Rs 657 crore, with EBITDA soaring 186%. Analysts from CLSA and Jefferies maintain positive ratings, citing strong growth momentum…

The Economic Times

Nykaa, Honasa Consumer profits pop; Viral 'Cockroach Party' curbed on X

New-age companies Nykaa and Honasa Consumer posted multifold jumps in their quarterly profit. This and more in today’s ETtech Top 5.

The Economic Times

Honasa Consumer Q4 results: Profit more than doubles to Rs 69 cr; co declares Rs 3 dividend

Honasa Consumer reported Q4 FY26 profit more than doubled to Rs 69 crore and record revenue of Rs 682 crore (28% YoY). Full-year PAT reached Rs 200 crore. Driven by stronger execution, offline expansion, and growth across core and younger brands, including new acquisition Reginald Men, the company declared a…

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Honasa Consumer Q4 profit rises to Rs 69.4 crore, declares dividend of Rs 3 per share

Honasa Consumer, the parent company of Mamaearth, reported a significant jump in its March quarter net profit. Profit rose 177.6% year-on-year to Rs 69.4 crore. Operating revenue also saw an increase of 23% to Rs 657 crore. The company announced its first-ever dividend of Rs 3 per share.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.